Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$227.28 +2.18 (+0.97%)
At close: Oct 22, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Return on Assets [ROA] (2010 - 2026)

Updated

Alnylam Pharmaceuticals' Return on Assets [ROA] was 14.50% in Q2 2026, up 21.01 percentage points from -6.51% a year earlier and up 3.84 percentage points from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Return on Assets [ROA] (2010 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Alnylam Pharmaceuticals came in at 6.82%, up 13.71 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +36.40 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -6.89% in FY2024 (+5.04 pp), -11.94% in FY2023 (+19.53 pp), -31.47% in FY2022 (-7.27 pp) and -24.19% in FY2021 (+5.39 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q3 2010.
  • Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +8.77 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 29.44 percentage points); the worst was Q3 2022 (a drop of 10.43 percentage points).
  • Per Business Quant data, ALNY's Return on Assets [ROA] in the three quarters before Q2 2026 was 10.66% (Q1 2026), 6.39% (Q4 2025) and 2.52% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 8.08%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 4.65%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.45%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 9.10%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 9.29%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -6.13%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 2.14%
10 Alnylam Pharmaceuticals 30.40 Bn 18.44 Bn 992.69 Mn 14.50%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.50%
Mar 31, 2026 10.66%
Dec 31, 2025 6.39%
Sep 30, 2025 2.52%
Jun 30, 2025 -6.51%
Mar 31, 2025 -5.45%
Dec 31, 2024 -6.59%
Sep 30, 2024 -8.09%
Jun 30, 2024 -1.86%
Mar 31, 2024 -8.68%
Dec 31, 2023 -11.48%
Sep 30, 2023 -14.08%
Jun 30, 2023 -31.31%
Mar 31, 2023 -30.70%
Dec 31, 2022 -31.95%
Sep 30, 2022 -34.44%
Jun 30, 2022 -29.00%
Mar 31, 2022 -25.23%
Dec 31, 2021 -23.97%
Sep 30, 2021 -24.00%
API Access

Alnylam Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALNY&period=max&api_key=YOUR_API_KEY